What can proteomics teach us about infectious disease
Dr. Coomb’s group has used the SomaScan® Assay to screen >1,300 host proteins in Zika virus-infected cells, both globally and specifically in the central nervous system. Significant findings include the identification of nearly 300 astrocyte proteins that were significantly dysregulated by Zika infections, pointing to pathways that may be involved in neurological complications resulting from Zika, such as microcephaly and Guillain-Barré syndrome.
Dr. Coombs’ work in influenza has included extensive proteomic scanning of H5N1, H1N1, and H7N9 in various cell types including induced-pluripotent stem cells. Significant findings include the observation that low-pathogenicity strains induce less profound changes to the global proteome. For instance, avian strains stimulate significant downregulation of key proteins, including those involved in antimicrobial response. Seasonal strains do not elicit the same response. Further, Dr. Coombs’ team found that viral infection in stem cells can reduce pluripotency, activate autophagy, and lead to abnormal differentiation.
Key highlights include:
- Using proteomics to identify biological processes associated with infection
- Measuring proteomic changes in response to antimicrobials
- Comparing and contrasting cellular response to Zika and influenza
- Exploring how the SomaScan Assay could be used to study COVID-19
Kevin Coombs, Ph.D.
Professor of Medical Microbiology with cross-appointments in Physiology, Pathophysiology, and Microbiology the University of Manitoba
Dr. Kevin Coombs is a Professor in the Department of Medical Microbiology with cross-appointments in Physiology and Pathophysiology and in Microbiology. He serves on several Cell Biology, Molecular Biology, and Virology Editorial Boards and is currently Chair of the CIHR Virology & Viral Pathogenesis Committee.
Dr. Coombs received his B.A.s in Biology and English from the State University of New York in Geneseo and his M.A. and Ph.D. from the University of Texas in Austin. His post-doctoral training in molecular and structural virology was done in the labs of Drs. Bernie Fields and Steve Harrison at Harvard.
His research interests include delineation of the protein and nucleic acid interactions in nucleoprotein complexes, using a variety of RNA viruses as models. His lab studies how these interactions change as a result of, and in turn, are modulated by, conformational transitions that occur during macromolecular assembly and disassembly, how these processes can be attenuated by anti-viral compounds, and how these processes in virus infections contribute to pathogenesis in the host.
WebinarUtilizing proteomic strategies to uncover novel biomarkers and mechanisms in heart failure
Plasma proteomics is a powerful approach for discovering novel protein biomarkers of drug toxicity in various disease contexts. One such biomarker in cardiovascular disease is apolipoprotein M (ApoM), which plays a crucial role in lipid metabolism and transport and is known to have both anti-inflammatory and cardioprotective effects in the body. Studying ApoM using proteomics requires various approaches to understand its expression, modifications, interactions, and functions in the proteome.
WebinarUsing plasma proteomics to understand Alzheimer’s and other brain diseases
Dr. Walker discusses how he integrates proteomic, genetic, brain imaging and cerebral spinal fluid biomarkers from initially cognitively normal individuals who later develop dementia, in order to discover novel blood-based biomarkers and mechanistically relevant proteins for therapeutic target prioritization.
WebinarProteomics for precision neuroscience: The power of protein analysis
This webcast highlights how academic, industry and government researchers are directly measuring protein abundance and function via multiplex proteomics to build more detailed characterizations of the biological systems underlying neurodegenerative diseases.